Tianjin Tianyao Pharmaceuticals Co., Ltd. Drug For Further Processing
NDC Database

Tianjin Tianyao Pharmaceuticals Co., Ltd. Drug For Further Processing

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 3
  • Latest Marketing Date 2021-10-01
  • Data Source FDA
  • First Marketing Date 2020-12-01
All
11
View
Bulk Ingredient
8
View
Drug for Further Processing
3
View
Company Overview

Company

Tianjin Tianyao Pharmaceuticals Co., Ltd. Drug For Further Processing

Country

China

Website

Visit Website

Email

lixm1@tjpc.com.cn

Social Profiles

Company Snapshot

Tianjin Tianyao Pharmaceuticals Co., Ltd. Drug For Further Processing

No.19, XINYE 9th Street, West Area of Tianjin Economic-Technological Development Area (TEDA), Tianjin  300 462

China

www.tjpc.com.cn/ lixm1@tjpc.com.cn View on Map
NDC Records ( 3 records )
2020
01 Dec
Drug for Further Processing NDC: 57582-032

Nonproprietary Name

Celecoxib

Dosage Form

POWDER

Strength

25 kg/25kg

Labeler

Tianjin Tianyao Pharmaceuticals Co., Ltd.

Marketing Category

DRUG FOR FURTHER PROCESSING

57582-032

Substance

CELECOXIB

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-12-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
10 Jun
Drug for Further Processing NDC: 57582-040

Nonproprietary Name

Deflazacort

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Tianjin Tianyao Pharmaceuticals Co., Ltd.

Marketing Category

DRUG FOR FURTHER PROCESSING

57582-040

Substance

DEFLAZACORT

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-06-10

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
01 Oct
Drug for Further Processing NDC: 57582-041

Nonproprietary Name

Trilostane

Dosage Form

POWDER

Strength

5 kg/5kg

Labeler

Tianjin Tianyao Pharmaceuticals Co., Ltd.

Marketing Category

DRUG FOR FURTHER PROCESSING

57582-041

Substance

TRILOSTANE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-10-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

Related Databases
  • FDA Inspections
    6 View
  • EDQM CEP
    20 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    11 View
  • FDA Approved Drugs Database
    10 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
3 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

57582-032

Nonproprietary Name

Celecoxib

Labeler

Tianjin Tianyao Pharmaceuticals Co., Ltd.

Dosage Form

POWDER

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit